In practice, medical treatments of CF patients use combinations of different families of drugs including CFTR potentiators/correctors, but also antibiotics, anti-inflammatory medications, bronchodilators, etc. It is not surprising that as medical research advances, new pharmacogenomic alleles are discovered to improve drug treatments for CF patients. This evidence concerns the gene CFTR and cystic fibrosis.